ArticleJournal of arrhythmia2025

Cost-effectiveness analyses to assess the value of reactive atrial-based anti-tachycardia pacing for patients with pacemakers and defibrillators: An Australian private healthcare system perspective.

Adam Gordois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.